Aldeyra Therapeutics Inc. | Mutual Funds
Mutual Funds that own Aldeyra Therapeutics Inc.
Fidelity Select Biotechnology Portfolio
1,016,231
4.84%
-60,221
0.09%
07/31/2018
Fidelity Advisor Biotechnology Fund
483,678
2.31%
-51,181
0.14%
07/31/2018
Vanguard Total Stock Market Index Fund
429,986
2.04%
0
0%
07/31/2018
iShares Russell 2000 ETF
333,375
1.59%
-177
0.01%
09/06/2018
Vanguard Extended Market Index Fund
220,568
1.05%
0
0%
07/31/2018
iShares Russell 2000 Growth ETF
162,621
0.78%
0
0.01%
09/06/2018
Fidelity Spartan Extended Market Index Fund
74,826
0.36%
0
0%
07/31/2018
iShares Micro Cap ETF
42,282
0.2%
0
0.03%
09/06/2018
Russell US Small Cap Equity Fund
33,738
0.16%
33,738
0.01%
04/30/2018
Schwab Small Cap Index Fund
29,700
0.14%
29,700
0.01%
06/30/2018
| Address |
131 Hartwell Avenue
Lexington Massachusetts 02421
United States
|
|
Employees
|
- |
| Website |
http://www.aldeyra.com |
| Updated |
07/08/2019 |
| Aldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. The company was founded by Thomas A. |
